ARTICLE | Company News
GSK submits Rezonic NDA
May 30, 2008 12:42 AM UTC
GlaxoSmithKline (LSE:GSK; NYSE:GSK) said it submitted an NDA last week for an IV and an oral formulation of Rezonic casopitant to prevent chemotherapy-induced nausea and vomiting (CINV) as an add-on t...